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Hepatocyte growth factor (HGF) is a promoter of hair follicle growth. We examined another HGF family member,
macrophage-stimulating protein (MSP), for its hair follicle-modulating properties. Western blotting revealed
presence of mature MSP in cultured human dermal papilla (DP) cells and bulbar dermal sheath (DS) cells, but not
non-bulbar DS cells. Immunohistology demonstrated expression of MSP receptor RON in the outer and inner root
sheaths, hair matrix cells, DP, and bulbar DS whereas non-follicular epithelium and some cells of the sweat glands
exhibited low-level receptor expression. Human hair follicles exposed in vitro for 8 d to 0.1, 1, 10, and 100 ng per mL
MSP all yielded a mean net increase in hair follicle length in excess of the mean baseline growth observed in
controls. MSP was incubated with agarose beads and injected subcutaneously into mice all 70 d old when a uniform
telogen state in dorsal skin was apparent. All eight mice receiving 1 lg MSP, and four of eight receiving 100 ng MSP
showed induction of anagen hair growth at the site of bead implantation by 16 d whereas eight mice implanted with
saline incubated beads had no hair growth. The data identify MSP as a modulator of hair growth.
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Epithelial appendage development requires complex cell
signaling and interaction both between epithelial cells and
between epithelia and mesoderm-derived dermis (Sengel,
1983; Chuong et al, 1996, 2001). Secretory signals are
believed to be a key component in communication and
regulation of cell proliferation, growth, differentiation, and
formation of epithelial appendages (McElwee and Hoff-
mann, 2000).
Hepatocyte growth factor (HGF) has previously been
identified as a powerful modulator of hair growth and may
play an important role in hair follicle development and cycling
(Lindner et al, 2000). Macrophage-stimulating protein (MSP)
is another member of the HGF family of growth factors and is
also known as hepatocyte growth factor-like protein (HGFL)
and scatter factor 2. MSP was initially identified as a factor
that promotes chemotactic responses in peritoneal resident
macrophages (Leonard and Skeel, 1976, 1979; Leonard,
1997). More recently, MSP has been shown to induce
keratinocyte growth (Wang et al, 1996a), liver cell morpho-
genesis, and motogenesis (Medico et al, 1996), prevent
apoptosis of epithelial cells separated from the extracellular
matrix (Danilkovitch et al, 2000; Danilkovitch-Miagkova and
Leonard, 2001), promote bone resorption by osteoclast cells
(Kurihara et al, 1996, 1998), and act as a neurotrophic factor
(Funakoshi and Nakamura, 2001; Stella et al, 2001).
MSP communicates with cells through binding a cell
surface receptor tyrosine kinase called RON (Receptuer
d’Origine Nantaise) in humans (also called macrophage
stimulating 1 receptor; MST1R) or STK in mice as distinct
from the cell receptor for HGF named MET (Ronsin et al,
1993; Wang et al, 1994b, 1995). RON is expressed during
embryogenesis primarily in the central and peripheral
nervous systems, developing bones, skin, lung, and
digestive tract epithelia (Gaudino et al, 1995; Quantin
et al, 1995; Thierry et al, 1995). This expression during
development suggests the RON receptor and its ligand
MSP are involved in the proliferation and development of
epithelial tissues, bones, and neuroendocrine derivatives
(Gaudino et al, 1995). RON is also known to be expressed
on mature peritoneal macrophages, endothelium, and
epithelia and may be upregulated in response to tissue
injury (Iwama et al, 1995; Sakamoto et al, 1997; Nanney
et al, 1998; Cowin et al, 2001). This relatively restricted
expression of RON/STK is in contrast to the HGF receptor
MET that is broadly expressed and mediates pleiotropic
biological functions such as cell growth, motility, and
morphogenesis (Sonnenberg et al, 1993).
Because of MSP’s close relationship to HGF, the distri-
bution of its receptor RON in human hair follicles was
examined and the effects of MSP on hair growth were
evaluated with functional studies. The results demonstrated
a significant hair growth-promoting impact for MSP on hair
follicles.
Results
MSP promotes growth of human hair follicles ex vivo
Culture of human hair follicles with MSP demonstrated a net
Abbreviations: DP, dermal papilla; DS, dermal sheath; DSC, dermal
sheath cup; HGF, hepatocyte growth factor; MSP, macrophage-
stimulating protein; PBS, phosphate-buffered saline; RON, Recep-
tuer d’Origine Nantaise; STK, stem cell-derived tyrosine kinase
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increase in hair growth rates in those follicles exposed
to MSP as compared with controls. Little difference in the
hair follicle growth rates was observed between the five
donors and the results were combined (Fig 1). Using the
micrometer measurements from day 8 of culture, the
statistical significance of increased hair growth only
reached the 95% confidence interval in follicles exposed
to 1 ng of MSP as compared with controls. Probability
values of 0.255, 0.036, 0.156, and 0.263 were obtained for
hair follicles exposed to 0.1, 1, 10, and 100 ng per mL MSP,
respectively.
MSP induces anagen in telogen stage hair follicles
in vivo Previous studies have demonstrated recombinant
human MSP can successfully stimulate mouse keratino-
cytes (Wang et al, 1996a). Here, recombinant human MSP
was examined for its ability to modulate hair growth in C3H/
HeJ mice. All eight 70-d-old mice implanted with agarose
beads containing 1 mg of MSP exhibited a marked response
with hair growth visible in skin immediately above the
location of the beads (Fig 2A). Hair growth was first
observed on day 16 post-implantation simultaneously in
all mice exposed to MSP. The second group of eight mice
receiving 100 ng of MSP in the same volume of agarose
beads showed a more limited response with only four of
eight demonstrating overt hair growth at the site of bead
implantation by necropsy (not shown). In contrast, eight
control mice exhibited no hair growth over the bead
implantation site or elsewhere in the shaved dorsal region
on day 16 and this state was maintained until necropsy, 24 d
after bead implantation (Fig 2B). Of eight mice that were
not implanted with beads and monitored for the onset
of spontaneous anagen, four showed a change in skin
color, an indication of anagen onset, on part of the shaved
dorsal surface when aged 104 d. All eight mice had dorsal
skin containing anagen stage follicles when aged 110 d.
Histology at necropsy demonstrated hair follicles located
over beads incubated with 1 mg MSP were in anagen
whereas adjacent skin contained telogen stage hair follicles
(Fig 3A). Histology also confirmed that control mice pre-
sented a uniform telogen hair follicle state (Fig 3B).
All five aged C3H/HeJ mice receiving 1 mg of MSP
demonstrated a hair growth response over the site of bead
implantation and also exhibited hair growth beyond the
location of the beads. Hair growth was apparent simulta-
neously in all mice by day 13 post-bead implantation,
although control mice did not demonstrate visible hair
growth at this stage. Of five control mice, four revealed
limited hair growth in the shaved dorsal region, but not over
or immediately adjacent to the bead implantation site,
whereas one mouse had anagen hair growth over and
beyond the bead implantation site by day 17. These states
persisted until necropsy and all mice employed survived
until necropsy. Histology of the aged mice revealed that hair
follicles in skin above beads soaked in MSP were still in an
anagen state at necropsy whereas hair follicles beyond the
bead location were in telogen. Histology of control mice
revealed a telogen state in hair follicles above and
immediately adjacent to the site of bead implantation
including the mouse with apparent spontaneous hair growth
over the bead implantation site.
Figure1
Human hair follicle growth was accelerated in response to
macrophage-stimulating protein (MSP) exposure. Isolated hair
follicles incubated in the presence of 0.1, 1, 10, or 100 ng per mL of
MSP over 8 d all demonstrated a degree of increased growth as
compared with controls.
Figure2
Implantation of agarose beads incubated with macrophage-
stimulating protein (MSP)-induced anagen in telogen stage pelage
follicles. Agarose beads incubated with MSP were injected subcuta-
neously to female mice aged 70 d when dorsal pelage follicles are in a
uniform telogen state. By day 92 mice receiving 1 mg of MSP all
exhibited some degree of anagen hair growth over the bead
implantation site (A) whereas control mice demonstrated no hair
growth over or beyond the site of bead implantation (B).
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Mice implanted with agarose beads containing 1 mg of
recombinant human MSP at 10 d of age and necropsied
when 20 d old revealed that a minority of pelage hair follicles
above the location of the beads were maintained in an
anagen state whereas hair follicles in pelage skin adjacent
to the location of the beads were uniformly in telogen (Fig
3C,D). Comparative control mice exhibited a uniform
telogen in all pelage hair follicles over the site of bead
location and adjacent to it.
All mice employed in the studies described demon-
strated no apparent abnormalities or responses to agarose
bead implantation other than those described above.
Although MSP is known as a stimulator of peritoneal
macrophage cells, no apparent inflammation at the site of
MSP-soaked agarose bead implantation was observed.
Control mice receiving agarose beads not exposed to MSP
were also devoid of inflammation. Other than the presence
of agarose beads in a subcutaneous location and a hair
growth response to MSP exposure, no other morphological
abnormalities were apparent in the skin of study mice.
RON receptor is expressed in the hair follicle epithelium
and mesenchyme and mature MSP is present in the hair
follicle mesenchymal component Using an antibody
reactive against the human MSP receptor RON, we
identified expression of the receptor predominantly located
in the inner root sheath of anagen stage human hair follicles
as well as the outer root sheath, differentiating hair matrix,
DP and some cells of the DSC (Fig 4). A low level of
expression in keratinocytes of the non-follicular epithelium
was also observed. Apparent expression of the RON
receptor in the arrector pili muscle was shown to be largely
non-specific by peptide depletion controls. The anti-MSP
antibody described failed to identify tissue MSP expression
suggesting the unsuitability of this antibody for immuno-
histological techniques. Consequently, a western blotting
Figure 3
Exposure to macrophage-stimulating protein (MSP)-induced ana-
gen in telogen stage hair follicles and enabled prolongation of
anagen in a small subset of hair follicles. At necropsy, mice aged 94
d implanted with MSP-soaked beads demonstrated anagen stage hair
follicles in the immediate vicinity of the beads (A) whereas control mice
exhibited uniform telogen stage follicles (B). Mice age 20 d exposed to
MSP presented with a few isolated hair follicles in an anagen state,
most pronounced when associated with beads that had penetrated to
an intradermal location (C). In contrast, control mice had a uniform
telogen state over subcutaneous and intradermally located beads (D).
Scale bar¼ 500 mM.
Figure4
Macrophage-stimulating protein (MSP) receptor Receptuer d’Ori-
gine Nantaise (RON) is broadly expressed in human hair follicles.
Sections of normal human scalp skin were processed for peptide–
antibody depleted controls (A, C) in comparison with RON receptor
distribution by immunohistology (B, D–H). As compared with peptide
control (A), presence of RON in hair follicle outer root sheath was most
striking (B). Peptide–antibody depleted control tissue samples (C)
revealed that apparent intense expression in the arrector pili muscle in
test tissues (D) was likely non-specific binding of the antibody. Slight,
but specific RON expression was observed in the basal layer of non-
follicular epithelium (E). RON expression was present with greater
intensity in the outer and inner root sheath and hair matrix (F, G)
although expression was also apparent to a lesser extent in the dermal
papilla and some dermal sheath cup cells, of anagen stage hair follicles
(H). Scale bars¼ 100 mM.
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approach was employed and indicated consistent presence
of mature, bioactive MSP in both the cytosol and membrane
fractions from cultured DP-derived cells and to a lesser
extent in DSC-derived cells. The mature form of MSP was
not observed in DS-derived cells, only the pro-MSP
precursor was identified in the DS cell membrane fraction.
(Fig 5).
Discussion
As a member of the HGF family of cytokines, and given HGF
is known to modulate hair follicle growth among many other
properties (Jindo et al, 1998; Lindner et al, 2000), MSP was
investigated for its respective action on hair follicles. MSP
acts on cells through binding a cell surface receptor tyrosine
kinase called RON in humans or STK in mice as distinct
from the cell receptor for HGF named MET (Ronsin et al,
1993; Wang et al, 1994b, 1995). Functional absence of MSP
in knockout mice has little immediately noticeable impact
(Bezerra et al, 1998), although the parameters of hair growth
in such mice is not known. In contrast, complete absence of
RON/STK expression in knockout mice leads to early
embryonic death demonstrating a fundamental requirement
for RON and suggesting that in addition to MSP there are
other, as yet unknown, factors that can ligand with RON/
STK (Muraoka et al, 1999).
RON/STK receptors act via a two-phosphotyrosine
docking site, capable of concomitant activation of multiple
intracellular transducers and signalling pathways (Tamag-
none and Comoglio, 1997). RON/STK mRNA is translated
into a glycosylated precursor that is cleaved into a 185-kDa
heterodimer of 35-kDa (a) and 150-kDa (b) subunits joined
by disulfide linkage. HGF stimulation has no effect on RON
receptor activation, but upon stimulation by MSP the b
chain of RON/STK undergoes tyrosine phosphorylation
(Gaudino et al, 1994). Both the MSP a and b chain
heterodimer and the b chain alone can bind to the RON
receptor, but only the heterodimeric MSP induces RON/
STK receptor dimerization and activation (Leonard, 1997;
Tamagnone and Comoglio, 1997; Wang et al, 1997). Down-
stream events after receptor liganding are poorly under-
stood, but studies suggest the RON receptor may regulate
phosphorylation of b catenin (Danilkovitch-Miagkova et al,
2001), a key factor in hair follicle morphogenesis and growth
(Gat et al, 1998). Immunohistology defined expression of the
RON/STK receptor for MSP to be dominant within kerati-
nocyte cells of the anagen stage hair follicle in humans.
Other studies suggest that some degree of RON/STK may
be expressed on most keratinocyte cells (Wang et al, 1996a)
and we observed low levels of positive staining by
immunohistology in the non-follicular epidermis. However,
more intense expression of RON/STK in epidermal appen-
dages indicates these structures are most likely to respond
to MSP and MSP may elicit the greatest response in cells
with high RON/STK expression.
MSP is an 80 kDa disulfide-linked heterodimeric protein
containing a 452 amino acid residue a chain and a 228
amino acid b chain with molecular masses of 52 and 25
kDa, respectively (Yoshikawa et al, 1999). Due to glycosyla-
tion, the a and b chains migrate as 56 and 30 kDa proteins
in SDS-PAGE (Skeel et al, 1991; Yoshimura et al, 1993,
1999). Like HGF, MSP is secreted as a single-chain inactive
precursor pro-MSP. It is converted to an active heterodimer
form through proteolytic cleavage by kallikrein, factor XIIa,
factor XIa, nerve growth factor-g (NGF-g), and epidermal
growth factor-binding protein (EGF-BP), the serine protease
subunits of NGF and EGF (Wang et al, 1994a–c). This
suggests possible cooperative interaction between NGF-g
or EGF-BP and pro-MSP in inflammation and wound
healing (Wang et al, 1994a; Nanney et al, 1998). Western
blotting against cultured cells from the DP, DSC, and DS
mesenchymal hair follicle components demonstrated high-
est expression of mature MSP in cell membrane and cytosol
fractions of DP cells and lowest expression in DS cells,
while expression in DSC cells was intermediate. This pre-
sence of mature MSP suggests the potential of the hair
follicle mesenchymal component to cleave pro-MSP into
a mature, active form, and possibly to signal to the
epithelium-derived component.
The ex vivo results demonstrated that MSP can stimulate
increased rates of hair growth in excess of that seen in hair
follicles not exposed to MSP in the first 8 d of hair follicle
culture. A superior accelerated growth rate was obtained
with an MSP concentration in the range of 1 ng per mL, a
concentration similar to that defined for ex vivo studies
using HGF (Jindo et al, 1994, 1995; Shimaoka et al, 1995).
Implantation to C3H/HeJ mice of agarose beads soaked in
human recombinant MSP demonstrated that MSP has a
limited capability to prolong the anagen growth phase of the
primary pelage coat generation in young mice, comple-
menting the results of ex vivo human hair follicle culture
studies. Implantation of MSP incubated agarose beads to
mice with dorsal telogen stage hair follicles were also
capable of inducing an anagen growth state until necropsy.
As such, MSP may be involved in modulating hair growth
Figure 5
Macrophage-stimulating protein (MSP) is present in cultured
dermal papilla (DP) and dermal sheath cup (DSC) cells. Western
blotting using recombinant human MSP as a positive control (lane 1)
and extracts from cultured DP (cytosol, lane 2; membrane, lane 5), DSC
(cytosol, lane 3; membrane, lane 6), and DS (cytosol, lane 4; membrane,
lane 7), derived cells. Pro-MSP, the single-chain inactive precursor of
mature active MSP, was observed in membrane fractions from all three
cell types, DP (lane 5), DSC (lane 6), and DS (lane 7) as an 80 kDa band.
The membrane fractions of DP and DSC, but not DS cells also
exhibited a band at 56 kDa for the a chain of mature MSP and with
greatest intensity in DP cell membranes. Cytosol extracts from DP (lane
2) and to a lesser extent DSC (lane 3) cells exhibited presence of an
MSP a chain band. In contrast, the cytosol of DS cells did not contain
the mature form of MSP (Lane 4).
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and analogs may have potential for treating alopecias in
which there is an increase in the frequency of telogen stage
hair follicles and low levels of hair growth.
Materials and Methods
MSP action on human hair follicles ex vivo Protocols, similar to
those used in previously published research on HGF (Jindo et al,
1995; Shimaoka et al, 1995), were employed to define the
functional effects of MSP on human hair follicles. Five healthy
human volunteers (two females, three males, mean age 27 y) at the
Philipp University Department of Dermatology provided occipital
scalp skin samples, with informed consent and according to
Hospital Ethics Committee regulations, from which hair follicles
were isolated by removing the epidermis and ‘‘plucking’’ the hair
follicles with forceps from the dermis (Eicheler et al, 1998). Whole
hair follicles were placed in Williams E medium, supplemented with
insulin (10 mg per mL), L-glutamine (2 mM), penicillin (100 U per
mL), and streptomycin (100 mg per mL) (Gibco Invitrogen GmbH,
Karlsruhe, Germany) in 24-well culture plates (Falcon, Franklin
Lakes, New Jersey) incubated at 371C in 5% CO2. Hair follicles
from each donor were separated into groups and 0.1, 1, 10, and
100 ng per mL recombinant human MSP (R&D systems,
Minneapolis, Minnesota) in phosphate-buffered saline (PBS) was
added whereas control follicles received PBS vehicle alone. Hair
follicle length was measured on day 0 using a Nikon inverted
microscope with a digital camera and LuciaM software (version
2.995, Nikon GmbH, Du¨sseldorf, Germany) and at regular
intervals after initiation of culture. Medium including MSP was
replaced twice during the 8-d analysis period. Follicles that
exhibited catagen, with dissecting microscope examination, or
presented with no growth or an unusually high growth rate,
indicative of a follicle in an early anagen state, were excluded from
final analysis. Thirty-six control follicles were compared with 16
exposed to 0.1 ng, 30 receiving 1 ng, 18 with 10 ng, and 18
exposed to 100 ng of MSP. Hair growth on day 8 of in vitro culture
with each MSP concentration was compared with the control
group using two-tailed t tests.
In vivo analysis of MSP To characterize the effects of MSP on
hair follicles in vivo, recombinant human MSP was administered to
mice in various states of hair growth. Normal haired C3H/HeJ mice
(The Jackson Laboratory, Bar Harbor, Maine) were utilized in all
studies. Mice received conventional low soy oil diet (Altromin 1434,
Altromin GmBH, Lage, Germany) and acidified water (pH 2.8–3.0)
ad libitum for the duration of the study.
Agarose bead preparation Agarose beads were prepared based
on previously published protocols (Botchkarev et al, 2001). Briefly,
250 mL of agarose beads in suspension as supplied (100–200 mesh
(80–150 mM), Bio Rad Laboratories Inc., Hercules, California)
were extensively washed with sterile PBS (Gibco Invitrogen) and
recombinant human MSP (R&D systems) at a concentration of 5 mg
per mL in PBS plus 0.5% C3H/HeJ mouse serum was added in a
quantity of 1 mg or 100 ng per 250 mL of original agarose bead
suspension. The agarose beads were incubated for 1 h at 371C.
For a comparative control, agarose beads were prepared in the
same way, but were incubated with PBS plus 0.5% C3H/HeJ
mouse serum alone. The agarose beads and solution were drawn
into a 1 mL syringe with a 22-gauge needle and additional sterile
PBS was added to permit injection of 150 mL of the agarose bead
suspension per mouse.
Agarose bead implantation To characterize the ability of MSP to
prolong the anagen growth phase of pelage hair follicles, eight
mice aged 10 d old, when pelage hair follicles are in anagen of the
first pelage coat generation (Dry, 1926), were implanted with a
single injection of agarose beads containing 1 mg of recombinant
human MSP per injection. Eight littermates received agarose
beads in suspension in the absence of MSP. The mice were
observed for a further 10 d and necropsied when 20 d old when
generation of the first pelage coat is normally complete and pelage
hair follicles of the dorsal skin are typically in telogen (Dry, 1926).
To characterize the ability of MSP to induce anagen in telogen
stage hair follicles, eight mice all aged 70 d, when the dorsal
pelage hair follicles are in a telogen resting state after completion
of the second coat generation (Dry, 1926), were each injected with
agarose beads in suspension providing 1 mg of MSP per mouse. A
further eight mice were injected with the same volume of agarose
beads providing 100 ng of MSP per mouse. Eight age-matched
mice received agarose beads unexposed to MSP as a control. The
24 mice were observed for 24 d and all were necropsied aged 94 d.
A further eight mice of the same age did not receive agarose beads
and were observed indefinitely to define the spontaneous onset of
anagen.
To further characterize the effects of MSP on hair follicles in
aging C3H/HeJ mice, a large number of mice all aged 246 d were
shaved on their dorsal surface and those mice exhibiting a uniform
telogen stage skin were selected for use. Five mice were injected
with agarose beads in suspension providing 1 mg of MSP per
mouse. Five mice served as controls receiving beads not exposed
to MSP. The mice were observed for 24 d and all were necropsied
aged 270 d.
Dorsal skin samples, including the site of bead implantation and
skin surrounding the implantation, were fixed in Fekete’s acid–
alcohol–formalin solution, paraffin embedded, sectioned at 6 mM
through the area of bead implantation, and stained with hemato-
xylin and eosin for histologic evaluation (Relyea et al, 1999).
Immunohistology Immunohistology was performed on 6 mM
cryostat tissue sections of human hair follicles. Briefly, tissue
alkaline phosphatase acivity was ablated with levamisole solution
and non-specific binding blocked using an avidin–biotin blocking
kit (Vector Laboratories Inc., Burlingame, California) and 2%
normal goat serum. Immunohistology for the MSP receptor RON
was conducted using a polyclonal antibody against human RON
(RON (N-20), sc-14627, Santa Cruz Biotechnology Inc., Santa
Cruz, California). Biotinylated swine anti-goat (Cedarlane Labs.,
Hornby, Ontario), alkaline phostphatase-conjugated avidin–biotin
complex (Vector Laboratories Inc.), and fast red development
substrate (Pierce Chemical Co., Rockford, Illinois) solutions were
applied in sequence. Tissue sections were counterstained with
Mayer’s Hematoxylin. The primary antibodies were replaced with
species and isotype-matched serum for negative controls. In
addition, the peptide sequence (Santa Cruz) to which the RON-
specific antibody was raised, was used in peptide depletion
controls according to manufacturer’s instructions. After preliminary
screens to identify appropriate antibody dilution parameters, the
procedure repeated on more than ten separate occasions for each
antibody using multiple tissue sections from three different human
donors (two males, one female).
Western blotting MSP expression by the hair follicle mesench-
ymal component Human hair follicles from two donors were
dissected and the dermal papilla (DP), peri-bulbar dermal sheath
‘‘cup’’ (DSC), and non-bulbar dermal sheath (DS) mesenchymal
components were isolated for culture as described elsewhere
(Eicheler et al, 1998). All cells regardless of source were cultured
under the same conditions. Hair follicle subunits derived from
an individual donor were maintained as separate cultures. DP,
DS, or DSC units were placed in 1 mL of AmnioMax–C100 basal
medium plus AmnioMax–C100 supplement (Gibco Invitrogen) in
24-well culture plates (Falcon) incubated at 371C in 5% CO2.
Culture conditions and medium were such that any contaminating
keratinocytes were non-proliferative as confirmed by in vitro
observation. Proliferating DP-, DS-, or DSC-derived cells were
subsequently passaged a maximum of two times into 25 mL
culture flasks (Greiner, Frickenhausen, Germany) to produce
1  107þ cells per culture.
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The cell cytosol and membranes were fractionated by physical
dissociation of cells in lysis buffer (10 mM Tris-HCl, pH 8.0, 0.1 mM
ethylenediamine tetraacetic acid, 10 mM MgCl2, 3 mM dithiothrei-
tol, 50 mM NaCl, 17.2 mM phenylmethylsulfonyl fluoride) and
centrifugation at 300,000 g for 30 min at 41C. Membrane and
cytosol fractions from DP, DSC, and DS cells were subsequently
resolved by sodium dodecyl sulfate polyacrylamide gel electro-
phoresis (SDS-PAGE: 12% polyacrylamide) using 20 mg of extract
per lane. For western blots, gels were transferred to membranes
(Hybond ECL, Amersham Biosciences GmbH, Freiburg, Germany)
using a semi-dry blotting apparatus. Membranes were blocked
with 5% non-fat milk powder in PBS overnight at 41C and washed
with 0.5% Tween 20 (Sigma-Aldrich GmbH, Munich, Germany)
in PBS. Polyclonal goat anti-human antibody specific for the MSP
a chain was utilized to detect both the pro-MSP precursor
and mature form of MSP (HGFL (N-19), sc-6088, Santa Cruz).
Recombinant human MSP (R&D systems) was employed for a
positive control and peptide depletion (Santa Cruz) was utilized as
a negative control. Anti goat HRP-conjugated secondary antibody
(Amersham) and ECL detection reagents (Amersham) prepared as
per manufacturers instructions, were applied in sequence.
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